{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T18:20:24Z","timestamp":1784139624967,"version":"3.55.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["ajogmfm.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.ajogmf.2024.101544","type":"journal-article","created":{"date-parts":[[2024,11,4]],"date-time":"2024-11-04T22:20:15Z","timestamp":1730758815000},"page":"101544","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Substance use disorder and severe maternal morbidity: is there a differential impact?"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7976-7380","authenticated-orcid":false,"given":"Justine M.","family":"Keller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noor","family":"Al-Hammadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabel","family":"Bass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niraj R.","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajogmf.2024.101544_bib0001","unstructured":"Centers for Disease Control and Prevention. 25 April, 2024. Treatment of substance use disorders. https:\/\/www.cdc.gov\/overdose-prevention\/treatment\/index.html. Accessed December 2, 2024."},{"key":"10.1016\/j.ajogmf.2024.101544_bib0002","unstructured":"2022 National Survey on Drug Use and Health (NSDUH) Releases. 2022;https:\/\/samhsa.gov\/data\/release\/2022-national-survey-drug-use-and-health-nsduh-releases. Accessed June 23, 2024."},{"issue":"10","key":"10.1016\/j.ajogmf.2024.101544_bib0003","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jogc.2017.07.005","article-title":"Epidemiology and effects of substance use in pregnancy","volume":"39","author":"Cook","year":"2017","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0004","unstructured":"Substance Abuse and Mental Health Services Administration. July 2022. 2020 National Survey on Drug Use and Health: Women. https:\/\/www.samhsa.gov\/data\/sites\/default\/files\/reports\/slides-2020-nsduh\/2020NSDUHWomenSlides072522.pdf. Accessed December 2, 2024."},{"key":"10.1016\/j.ajogmf.2024.101544_bib0005","series-title":"Medication-assisted treatment for opioid addiction in opioid treatment programs","first-page":"12","year":"2005"},{"issue":"11","key":"10.1016\/j.ajogmf.2024.101544_bib0006","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11920-015-0626-5","article-title":"Substance use in the perinatal period","volume":"17","author":"Forray","year":"2015","journal-title":"Curr Psychiatry Rep"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0007","article-title":"Perinatal substance use disorder: examining the impact on adverse pregnancy outcomes","volume":"22","author":"Ragsdale","year":"2024","journal-title":"Eur J Obstet Gynecol Reprod Biol X"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0008","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1089\/jwh.2023.0619","article-title":"Racial and ethnic disparities among pregnancies with substance use disorder: impact on perinatal outcomes","volume":"33","author":"Ragsdale","year":"2024","journal-title":"J Womens Health (Larchmt)"},{"issue":"3","key":"10.1016\/j.ajogmf.2024.101544_bib0009","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.bpobgyn.2009.01.007","article-title":"Maternal near miss\u2014towards a standard tool for monitoring quality of maternal health care","volume":"23","author":"Say","year":"2009","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0010","unstructured":"Prevention CfDCa. Severe maternal morbidity in the United States.https:\/\/www.cdc.gov\/reproductivehealth\/maternalinfanthealth\/severematernalmorbidity.html#anchor_how. Accessed February 23, 2023."},{"issue":"2","key":"10.1016\/j.ajogmf.2024.101544_bib0011","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1097\/AOG.0000000000002114","article-title":"Pregnancy-related mortality in the United States, 2011-2013","volume":"130","author":"Creanga","year":"2017","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0012","doi-asserted-by":"crossref","unstructured":"Hoyert DL. Maternal mortality rates in the United States, 2019. NCHS Health E-Stats. 2021. https:\/\/doi.org\/10.15620\/cdc:103855.","DOI":"10.15620\/cdc:103855"},{"issue":"2","key":"10.1016\/j.ajogmf.2024.101544_bib0013","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36148","article-title":"Assessment of incidence and factors associated with severe maternal morbidity after delivery discharge among women in the US","volume":"4","author":"Chen","year":"2021","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2020.108236","article-title":"Substance use disorders and risk of severe maternal morbidity in the United States","volume":"216","author":"Jarlenski","year":"2020","journal-title":"Drug Alcohol Depend"},{"issue":"5","key":"10.1016\/j.ajogmf.2024.101544_bib0015","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.whi.2023.06.002","article-title":"Risk of severe maternal morbidity in birthing people with opioid use disorder","volume":"33","author":"Osei-Poku","year":"2023","journal-title":"Womens Health Issues"},{"issue":"9","key":"10.1016\/j.ajogmf.2024.101544_bib0016","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1111\/acer.14671","article-title":"Association of alcohol and other substance-related diagnoses with severe maternal morbidity","volume":"45","author":"Courchesne","year":"2021","journal-title":"Alcohol Clin Exp Res"},{"issue":"1","key":"10.1016\/j.ajogmf.2024.101544_bib0017","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101221","article-title":"Co-occurring opioid and methamphetamine use disorder and severe maternal morbidity and mortality in Utah","volume":"6","author":"Smid","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"issue":"9","key":"10.1016\/j.ajogmf.2024.101544_bib0018","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1055\/s-0038-1667291","article-title":"Drug use during pregnancy and its consequences: a nested case control study on severe maternal morbidity","volume":"40","author":"Pereira","year":"2018","journal-title":"Rev Bras Ginecol Obstet"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0019","doi-asserted-by":"crossref","DOI":"10.1016\/j.addbeh.2021.107214","article-title":"Intimate partner violence as a predictor of substance use outcomes among women: a systematic review","volume":"127","author":"Ogden","year":"2022","journal-title":"Addict Behav"},{"key":"10.1016\/j.ajogmf.2024.101544_bib0020","unstructured":"Administration) SSAaMHS. Co-occurring disorders and other health conditions. [Webpage].https:\/\/www.samhsa.gov\/medications-substance-use-disorders\/medications-counseling-related-conditions\/co-occurring-disorders#:\u223c:text=HIV%2C%20AIDS%2C%20and%20viral%20hepatitis%20are%20important%20public%20health%20concerns,injection%20practices%20and%20unsafe%20sex. Accessed August 28, 2024."},{"key":"10.1016\/j.ajogmf.2024.101544_bib0021","unstructured":"Trost SL BA, Leonard M, et al. Pregnancy-Related Deaths: Data from Maternal Mortality Review Committees in 38 U.S. States, 2020.: Centers for Disease Control and Prevention, U.S. Department of Health and Human Services; 2024."},{"issue":"3","key":"10.1016\/j.ajogmf.2024.101544_bib0022","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.whi.2021.11.006","article-title":"Ways forward in preventing severe maternal morbidity and maternal health inequities: conceptual frameworks, definitions, and data, from a population health perspective","volume":"32","author":"Carmichael","year":"2022","journal-title":"Womens Health Issues"},{"issue":"12","key":"10.1016\/j.ajogmf.2024.101544_bib0023","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1097\/MLR.0000000000000608","article-title":"Examining race and ethnicity information in Medicare administrative data","volume":"55","author":"Filice","year":"2017","journal-title":"Med Care"},{"issue":"5","key":"10.1016\/j.ajogmf.2024.101544_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2015.11.004","article-title":"Measuring severe maternal morbidity: validation of potential measures","volume":"214","author":"Main","year":"2016","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics &amp; Gynecology MFM"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002702?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589933324002702?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T05:35:04Z","timestamp":1738647304000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589933324002702"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2589933324002702"],"URL":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101544","relation":{},"ISSN":["2589-9333"],"issn-type":[{"value":"2589-9333","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Substance use disorder and severe maternal morbidity: is there a differential impact?","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics & Gynecology MFM","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajogmf.2024.101544","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"101544"}}